Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

October 1, 2026

Conditions
Esophageal CancerEsophageal Carcinoma
Interventions
BEHAVIORAL

Exercise and Nutrition

"The exercise and nutrition intervention will last up to 8 weeks and will include:~* 3-5 times per week of resistance training and 3-5 times per week of aerobic training. The prescribed exercise will be personalized based on the participant's baseline functionality.~* IMPACT Advanced Recovery nutrition supplement drinks: 2 per day for 5 consecutive days leading up to surgery."

BEHAVIORAL

Usual Care Group

The CONT group will not receive any intervention during study participation and undergo usual medical treatment and surveillance during the duration of the study.

Trial Locations (1)

15213

RECRUITING

UPMC Hillman Cancer Center, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT06872515 - Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal) | Biotech Hunter | Biotech Hunter